Capricor Therapeutics, Inc. CAPR
11.22 USD +2.35 (+26.49%)
At closeNov 11, 2026, 7:59 PM EST
11.03 -0.19 -1.69%
After hours · Nov 11, 7:59 PM ET
9.01 Day range 11.23
3.85 52-week range 35.34
- YTD
- -61.12%
- 1 year
- +80.97%
CAPR revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | -22,270,465 | -100.00% |
| FY 2024 | 2024-12-31 | 22,270,465 | -2,907,601 | -11.55% |
| FY 2023 | 2023-12-31 | 25,178,066 | 22,626,597 | 886.81% |
| FY 2022 | 2022-12-31 | 2,551,469 | 2,306,571 | 941.85% |
| FY 2021 | 2021-12-31 | 244,898 | -65,352 | -21.06% |
| FY 2020 | 2020-12-31 | 310,250 | -694,778 | -69.13% |
| FY 2019 | 2019-12-31 | 1,005,028 | -666,328 | -39.87% |
| FY 2018 | 2018-12-31 | 1,671,356 | -994,984 | -37.32% |
| FY 2017 | 2017-12-31 | 2,666,340 | -1,332,278 | -33.32% |
| FY 2016 | 2016-12-31 | 3,998,618 | -1,519,030 | -27.53% |
| FY 2015 | 2015-12-31 | 5,517,648 | 730,948 | 15.27% |
| FY 2014 | 2014-12-31 | 4,786,700 | 4,283,467 | 851.19% |
| FY 2013 | 2013-12-31 | 503,233 | -1,395,531 | -73.50% |
| FY 2012 | 2012-12-31 | 1,898,764 | 544,264 | 40.18% |
| FY 2011 | 2011-12-31 | 1,354,500 | 1,354,500 | Not meaningful |
| FY 2010 | 2010-12-31 | 0 | 0 | Not meaningful |
| FY 2009 | 2009-12-31 | 0 | 0 | Not meaningful |
| FY 2008 | 2008-12-31 | 0 | -101,400 | -100.00% |
| FY 2007 | 2007-12-31 | 101,400 | -279,435 | -73.37% |
| FY 2006 | 2006-12-31 | 380,835 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-17T06:01:36.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.